Cargando…
Preoperative prophylactic active vitamin D to streamline total thyroidectomy
BACKGROUND: Hypocalcaemia is a common complication after total thyroidectomy (TT). Treatment consists of calcium and active vitamin D supplementation. Low levels of vitamin D before surgery have been shown to be a risk factor for postoperative hypocalcaemia, yet studies examining routine preoperativ...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155618/ https://www.ncbi.nlm.nih.gov/pubmed/35640612 http://dx.doi.org/10.1093/bjsopen/zrac060 |
_version_ | 1784718276652171264 |
---|---|
author | Annebäck, Matilda McHale Sjödin, Edward Hellman, Per Stålberg, Peter Norlén, Olov |
author_facet | Annebäck, Matilda McHale Sjödin, Edward Hellman, Per Stålberg, Peter Norlén, Olov |
author_sort | Annebäck, Matilda |
collection | PubMed |
description | BACKGROUND: Hypocalcaemia is a common complication after total thyroidectomy (TT). Treatment consists of calcium and active vitamin D supplementation. Low levels of vitamin D before surgery have been shown to be a risk factor for postoperative hypocalcaemia, yet studies examining routine preoperative vitamin D supplementation have shown conflicting results. This retrospective cohort study aims to investigate the potential benefit of preoperative active vitamin D supplementation on hypocalcaemia and its symptoms after TT. METHODS: This study included patients undergoing TT at Uppsala University Hospital from January 2013 to December 2020, resulting in a total of 401 patients after exclusion. Routine preoperative alfacalcidol treatment was initiated for all TT patients in January 2017 resulting in two groups for comparison: one group (pre-January 2017) that was prescribed preoperative alfacalcidol and one that was not. Propensity score matching was used to reduce bias. The primary outcome was early postoperative hypocalcaemia (serum calcium, S-Ca less than 2.10 mmol/l); secondary outcomes were symptoms of hypocalcaemia and length of stay. RESULTS: After propensity score matching, there were 108 patients in each group. There were 2 cases with postoperative day one S-Ca less than 2.10 in the treated group and 10 cases in the non-treated group (P < 0.001). No patients in the treated group had a S-Ca below 2.00 mmol/l. Preoperative alfacalcidol was associated with higher mean serum calcium level day one (2.33 versus 2.27, P = 0.022), and reduced duration of hospital stay (P < 0.001). There was also a trend toward fewer symptoms of hypocalcaemia (18.9 per cent versus 30.5 per cent, P = 0.099). CONCLUSIONS: Prophylactic preoperative alfacalcidol was associated with reduced biochemical hypocalcaemia and duration of hospital stay following TT. Also, with this protocol, it is suggested that routine day 1 postoperative S-Ca measurement is not required. |
format | Online Article Text |
id | pubmed-9155618 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91556182022-06-04 Preoperative prophylactic active vitamin D to streamline total thyroidectomy Annebäck, Matilda McHale Sjödin, Edward Hellman, Per Stålberg, Peter Norlén, Olov BJS Open Original Article BACKGROUND: Hypocalcaemia is a common complication after total thyroidectomy (TT). Treatment consists of calcium and active vitamin D supplementation. Low levels of vitamin D before surgery have been shown to be a risk factor for postoperative hypocalcaemia, yet studies examining routine preoperative vitamin D supplementation have shown conflicting results. This retrospective cohort study aims to investigate the potential benefit of preoperative active vitamin D supplementation on hypocalcaemia and its symptoms after TT. METHODS: This study included patients undergoing TT at Uppsala University Hospital from January 2013 to December 2020, resulting in a total of 401 patients after exclusion. Routine preoperative alfacalcidol treatment was initiated for all TT patients in January 2017 resulting in two groups for comparison: one group (pre-January 2017) that was prescribed preoperative alfacalcidol and one that was not. Propensity score matching was used to reduce bias. The primary outcome was early postoperative hypocalcaemia (serum calcium, S-Ca less than 2.10 mmol/l); secondary outcomes were symptoms of hypocalcaemia and length of stay. RESULTS: After propensity score matching, there were 108 patients in each group. There were 2 cases with postoperative day one S-Ca less than 2.10 in the treated group and 10 cases in the non-treated group (P < 0.001). No patients in the treated group had a S-Ca below 2.00 mmol/l. Preoperative alfacalcidol was associated with higher mean serum calcium level day one (2.33 versus 2.27, P = 0.022), and reduced duration of hospital stay (P < 0.001). There was also a trend toward fewer symptoms of hypocalcaemia (18.9 per cent versus 30.5 per cent, P = 0.099). CONCLUSIONS: Prophylactic preoperative alfacalcidol was associated with reduced biochemical hypocalcaemia and duration of hospital stay following TT. Also, with this protocol, it is suggested that routine day 1 postoperative S-Ca measurement is not required. Oxford University Press 2022-05-30 /pmc/articles/PMC9155618/ /pubmed/35640612 http://dx.doi.org/10.1093/bjsopen/zrac060 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of BJS Society Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Annebäck, Matilda McHale Sjödin, Edward Hellman, Per Stålberg, Peter Norlén, Olov Preoperative prophylactic active vitamin D to streamline total thyroidectomy |
title | Preoperative prophylactic active vitamin D to streamline total thyroidectomy |
title_full | Preoperative prophylactic active vitamin D to streamline total thyroidectomy |
title_fullStr | Preoperative prophylactic active vitamin D to streamline total thyroidectomy |
title_full_unstemmed | Preoperative prophylactic active vitamin D to streamline total thyroidectomy |
title_short | Preoperative prophylactic active vitamin D to streamline total thyroidectomy |
title_sort | preoperative prophylactic active vitamin d to streamline total thyroidectomy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155618/ https://www.ncbi.nlm.nih.gov/pubmed/35640612 http://dx.doi.org/10.1093/bjsopen/zrac060 |
work_keys_str_mv | AT annebackmatilda preoperativeprophylacticactivevitamindtostreamlinetotalthyroidectomy AT mchalesjodinedward preoperativeprophylacticactivevitamindtostreamlinetotalthyroidectomy AT hellmanper preoperativeprophylacticactivevitamindtostreamlinetotalthyroidectomy AT stalbergpeter preoperativeprophylacticactivevitamindtostreamlinetotalthyroidectomy AT norlenolov preoperativeprophylacticactivevitamindtostreamlinetotalthyroidectomy |